A new postdoctoral position is available immediately in the laboratory of Dr. Jennifer Herington at Vanderbilt University Medical Center, which is focused on the discovery of novel therapeutics and the use of targeted drug delivery to inhibit uterine myometrial contractility for prevention of preterm labor. The available position is to conduct exciting studies that will advance at a rapid pace to characterize the performance of new drug delivery systems (DDSs) to suppress uterine contractions that lead to preterm birth.  This is a collaborative project between an industrial partner that will fabricate drug conjugates for in vitro, ex vivo and in vivo tes